Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisPatricia Cortazar, Gϋnter von Minckwitz, Lijun Zhang et al.|The Lancet|2014Cited by 4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaTorsten O. Nielsen, Charles M. Perou|Clinical Cancer Research|2004Cited by 2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancerAleix Prat, Charles M. Perou, Joel S. Parker et al.|Breast Cancer Research|2010Cited by 2.1k
The molecular portraits of breast tumors are conserved across microarray platformsZhiyuan Hu, Charles M. Perou, Cheng Fan et al.|BMC Genomics|2006Cited by 1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J. Creighton, Jenny C. Chang, Xiaoxian Li et al.|Proceedings of the National Academy of Sciences|2009Cited by 1.4k